Literature DB >> 23889629

Body mass index, abdominal obesity, body fat and migraine features in women.

Vanessa Rossoni de Oliveira1, Fernanda Camboim Rockett, Kamila Castro, Alexandre da Silveira Perla, Márcia Lorena Fagundes Chaves, Ingrid D Schweigert Perry.   

Abstract

BACKGROUND: Studies seeking to establish an association between migraine and anthropometric parameters have thus far been inconclusive. Furthermore, drugs used for migraine prophylaxis may be associated with changes in body weight.
OBJECTIVE: To investigate the potential association of anthropometric parameters and body fat percentage with attack patterns and use of prophylactic medication in migraineurs.
METHODS: Cross-sectional study that assessed the body mass index, waist circumference, body fat percentage and related clinical variables (characteristics of attacks and the use of prophylactic medication) in female outpatients with migraine.
RESULTS: 166 female migraineurs aged ≥18 years (mean age, 45 ± 14 years) were included in the study. Migraine without aura was most prevalent (71.7%). Mean body mass index and body fat percentage were 27.8±6.0 kg/m² and 36.4 ± 8.3% respectively. Body mass index and waist circumference were weakly correlated with frequency of attacks over 6 months (rs = 0.162, p < 0.05 and rs = 0.187, p < 0.05 respectively). These correlations remains weak considering only premenopausal women, but disappear in the older women. Stratification of analysis by migraine type field shows a moderate correlation between migraine with aura and frequency of attacks over 6 months and body mass index (rs = 0.369, p < 0.05), as well as waist circumference (rs = 0.423, p < 0.01). Patients who were on prophylactic medication had higher body mass index, waist circumference, and body fat percentage values (p < 0.01, Student t-test).
CONCLUSION: This study revealed a potential, though tenuous association between migraine and anthropometric parameters and frequency of attacks, which does not reflect on the duration, severity, and disability of attacks, with patterns differing by migraine type, reproductive age and prophylactic medication.
Copyright © AULA MEDICA EDICIONES 2013. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23889629     DOI: 10.3305/nh.2013.28.4.6504

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  3 in total

Review 1.  Efficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studies.

Authors:  Maria Gabriella Saracco; Gianni Allais; Vincenzo Tullo; Dario Zava; Deborha Pezzola; Giorgio Reggiardo; Stefano Omboni; Chiara Benedetto; Gennaro Bussone; Marco Aguggia
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

2.  Body mass index and its association with various features of migraine: A cross-sectional study from Saudi Arabia.

Authors:  Danah Aljaafari; Noman Ishaque; Ghadeer Al-Shabeeb; Sukainah Alalwi; Aishah Albakr; Osama Basheir; Reem A Alyoubi; Fahd Alkhamis; Majed Alabdali
Journal:  Ann Afr Med       Date:  2021 Oct-Dec

3.  The association between abdominal obesity and characteristics of migraine attacks in Iranian adults.

Authors:  Omid Sadeghi; Gholamreza Askari; Zahra Maghsoudi; Reza Ghiasvand; Fariborz Khorvash
Journal:  Iran J Nurs Midwifery Res       Date:  2016 May-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.